Abstract
Human cancers utilise telomerase to maintain telomeres and prohibit cell senescence. Human telomerase reverse transcriptase (hTERT), an essential component of this complex, is regulated at the level of gene transcription. Using SILAC-proteomic analysis and molecular studies, we identified the AAA+ ATPase, RuvBl2 as a transcriptional regulator of hTERT and established that this regulation is through cooperation with Ets-2. In colon cancer patients, nuclear expression of RuvBl2 associated with nuclear expression of hTERT, pEts2 and advanced nodal disease (P < 0.01, P = 0.05 and P = 0.03 respectively, n = 170). These data firmly implicate RuvBl2 in Ets2 mediated regulation of hTERT in colon cancer which has functional and clinical consequences.
| Original language | English |
|---|---|
| Pages (from-to) | 2537-2544 |
| Number of pages | 8 |
| Journal | FEBS Letters |
| Volume | 585 |
| Issue number | 15 |
| DOIs | |
| Publication status | Published - 4 Aug 2011 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Colon cancer
- RuvBl2
- c-Myc
- hTERT
Fingerprint
Dive into the research topics of 'RuvBl2 cooperates with Ets2 to transcriptionally regulate hTERT in colon cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver